Navigation Links
China RuiTai Reports Fiscal Year 2007 Financial Results
Date:4/16/2008

TAI'AN, Shandong, China, April 16 /Xinhua-PRNewswire-FirstCall/ -- China RuiTai International Holdings Co., Ltd. (OTC Bulletin Board: CRUI) (''China RuiTai'' or ''the Company''), a leading producer and distributor of cellulose ether products in the People's Republic of China (''PRC''), today announced its financial results for the fiscal year ended December 31, 2007.

Fiscal Year 2007 Highlights

-- Sales increased 36.7% to $38.4 million

-- Gross profit increased 33.4% to $11.9 million

-- Gross profit margin was 31.0%

-- Operating income increased 52.3% to $8.1 million

-- Operating margin improved 216 basis points to 21.1%

-- Net income increased 62.2% to $4.9 million, or $0.23 per basic and

fully diluted share

-- Completed a production line to increase production capacity to 10,000

metric ton per year

-- Became a public company through a share exchange transaction in August

2007

''We are pleased to see continuous strong growth as our cellulose ether products continue to receive wide acceptance while meeting the worldwide expanding demand,'' commented Dianmin Ma, Chief Executive Officer and Chairman of China RuiTai. ''In 2007, we exported about 2,400 metric tons of cellulose ether products to foreign markets in the United States, Europe, India, the Middle East, and South East Asia. Our sales in the domestic market were about twice that of our international market. We expect further growth in the domestic and international markets in 2008 and beyond.''

Full Year 2007 Results

During the year ended December 31, 2007, sales were $38.4 million, an increase of 36.7% from $28.2 million for 2006. This was primarily due to increased order volumes from the Company's existing customers. Hydroxypropyl Methyl Cellulose (HPMC) remained the Company's top-selling product, accounting for 68.4% in 2007, compared to 66.0% in 2006.

Gross profit in 2007 was $11.9 mill
'/>"/>

SOURCE China RuiTai International Holdings Co., Ltd.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine news :

1. Chinas 1-child policy could backfire on its elderly
2. Omnicom Acquires Leading Healthcare Marketing Communications Firm in China
3. Expanding Prevalent Population Will Drive Dramatic Growth for the Asthma Drug Market in China
4. Bridgetech Announces Addition of the Agency for Healthcare Research and Quality as Content Provider in its Development of a Healthcare Web Portal in China
5. China Holdings Appoints Ronald Shon Chairman of Advisory Board to Its Wholly-Owned Subsidiary China Power, Inc.
6. China Bionanometer Industries Corporation Promotes New Cosmetics Product Line in China
7. China Shenghuo Pharmaceutical Holdings, Inc. Begins Full-Scale Launch of 12Ways(R) Chinese Herbal Skin Care Product Line
8. Statement by Mike Leavitt Secretary of Health and Human Services on the United States-China Bilateral Meetings on Food and Drug Safety
9. Supplier Assessments to Help Buyers Identify Reliable China Exporters
10. Study shows lead-based paint problem isnt isolated to China
11. Bracco Announces Initiative to Save Children in China at 2007 Annual Meeting of CGI
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2015)... On March 29, 2015 the United States celebrates ... all small business owners, for their commitment to their employees ... According to Zane Benefits' website, small businesses in the U.S. ... all jobs and employing over 60 million people. The 23 ... U.S. sales. The small business sector is growing rapidly, while ...
(Date:3/30/2015)... March 30, 2015 This report ... market over the forecast period of 2014 to ... a CAGR of 6.5% from 2014 to 2019. ... In this report, the global pharmacovigilance and drug ... segments on the basis of functionality, namely, adverse ...
(Date:3/30/2015)... 30, 2015 Recently, 10 Best Water ... Awards, with the top three winners being Fiji water, Tibet ... company’s website, along with other informative information about water. ... spring water, mineral water and sparkling water are among the ... the top exotic water brands highlighted on the site. ...
(Date:3/30/2015)... 2015 FMC Corporation’s Health and ... all current Epax® Ultra and Core concentrates manufactured ... The certification ensures the manufacturing process and all ... religious regulations for Halal. , The new ... to further advance its customer service to a ...
(Date:3/30/2015)... Slidezilla, an app from the makers of ... innovates the fun and simplicity of photo slideshows. The ... slideshows and then instantly share them across their Facebook, ... to create a slideshow app where users can share ... options to personalize them. You can choose your own ...
Breaking Medicine News(10 mins):Health News:Zane Benefits Puts Spotlight on Small Businesses for National Mom and Pop Business Owners Day 2Health News:The Global Pharmacovigilance and Drug Safety Software Market is Poised to reach the Value of $154.1 Million in 2019 - Report by MarketsandMarkets 2Health News:The Global Pharmacovigilance and Drug Safety Software Market is Poised to reach the Value of $154.1 Million in 2019 - Report by MarketsandMarkets 3Health News:The Global Pharmacovigilance and Drug Safety Software Market is Poised to reach the Value of $154.1 Million in 2019 - Report by MarketsandMarkets 4Health News:Best Exotic Water Brands Acclaimed by 10 Best Water 2Health News:FMC Health and Nutrition Announces Halal Certification for Epax® Brand Omega-3 Ingredients 2
... it, some of us believe it but science is skeptical ... between faith, health and healing. ,Some scientists also ... worship, and service to others, influence our health. ,The ... well” but a “holistic approach to wellness”, which unites the ...
... role in increasing death risk.// It is the incidence of ... him. ,Depression had long been taken as a factor ... team of researchers from Washington University School of Medicine in ... the prime cause for such a case. ,A ...
... been found to reduce the risk of cellular ... top of standard immunosuppression. ,The drug, a ... receptor, thereby inhibiting T-cell proliferation. ,Patients who ... daclizumab or a placebo. ,The primary endpoint ...
... A study conducted in the Department of Medicine at ... // regular sunscreen routine in childhood can reduce the ... ,"Sunscreen has always been an important part of ... reduce the number of sunburns, especially for children," said ...
... suffering from congenital central hypoventilation syndrome (CCHS) may suffer ... ,Congenital Central Hypoventilation Syndrome is the absence ... time. Children suffering from CCHS may not breathe regularly ... may be able to breathe during wakeful hours but ...
... Income inequalities make dying also different by nature. Surprising, but ... exits between the near death conditions and the financial health ... 70 yrs may be 30% less likely than their poorer ... their deaths. They also may experience lower number of symptoms ...
Cached Medicine News:Health News:Link between Faith, Health and Healing 2Health News:Link between Faith, Health and Healing 3Health News:Use Of Sunscreen In Childhood And Prevents Future Skin Cancer 2
(Date:3/30/2015)... PLAINS, N.Y. , March 30, 2015  A ... new treatments for patients with a rare and lethal ... a recent licensing agreement with a new biotechnology company, ... been funding this work, led by Assistant Professor ... Cierpicki , Ph.D., at the University of Michigan, since ...
(Date:3/30/2015)... Perrigo Company plc (NYSE: PRGO ; TASE), a ... announced that it has completed the acquisition of Belgian-based ... equity transaction valued at approximately €3.8 billion, which includes ... Marc Coucke , Waterland Private Equity Fund V ... "The combination of Perrigo and Omega creates an ...
(Date:3/30/2015)... Mar. 26, 2015 Research and Markets ... of the "Marine Biotechnology - Global Strategic ... Annual estimates and forecasts are provided for ... historic analysis is provided for these markets. Market ... secondary research. This report analyzes the ...
Breaking Medicine Technology:Leukemia Research Funded by The Leukemia & Lymphoma Society Gets Infusion of Support from Startup Biotechnology Company 2Leukemia Research Funded by The Leukemia & Lymphoma Society Gets Infusion of Support from Startup Biotechnology Company 3Perrigo Company plc Completes Acquisition Of Omega Pharma Invest N.V., Creating A Top Five Global OTC Company 2Perrigo Company plc Completes Acquisition Of Omega Pharma Invest N.V., Creating A Top Five Global OTC Company 3Perrigo Company plc Completes Acquisition Of Omega Pharma Invest N.V., Creating A Top Five Global OTC Company 4Perrigo Company plc Completes Acquisition Of Omega Pharma Invest N.V., Creating A Top Five Global OTC Company 5Marine Biotechnology - Global Strategic Business Report 2015-2020: Polysaccharides from Marine Microalgae Holds Tremendous Potential 2Marine Biotechnology - Global Strategic Business Report 2015-2020: Polysaccharides from Marine Microalgae Holds Tremendous Potential 3Marine Biotechnology - Global Strategic Business Report 2015-2020: Polysaccharides from Marine Microalgae Holds Tremendous Potential 4Marine Biotechnology - Global Strategic Business Report 2015-2020: Polysaccharides from Marine Microalgae Holds Tremendous Potential 5Marine Biotechnology - Global Strategic Business Report 2015-2020: Polysaccharides from Marine Microalgae Holds Tremendous Potential 6Marine Biotechnology - Global Strategic Business Report 2015-2020: Polysaccharides from Marine Microalgae Holds Tremendous Potential 7
... Repligen Corporation,(Nasdaq: RGEN ) announced today that ... to evaluate the use of RG1068, synthetic human ... by magnetic resonance,imaging (MRI). This Phase 3 study ... approximately 250 patients will receive an,unenhanced MRI followed ...
... First-in-Class Treatment for Type 2 Diabetes -, ... company focused on the discovery and development of,proprietary ... today that it has dosed the first cohort ... of MBX-2982, a potential first-in-class treatment,for type 2 ...
Cached Medicine Technology:Repligen Initiates Phase 3 Clinical Trial of RG1068 for Pancreatic MRI Imaging 2Repligen Initiates Phase 3 Clinical Trial of RG1068 for Pancreatic MRI Imaging 3Repligen Initiates Phase 3 Clinical Trial of RG1068 for Pancreatic MRI Imaging 4Metabolex Initiates Phase 1 Trial of MBX-2982 2
Attachments: Clip bar for tubes 10 to 19 mm in diameter Overall Dimension Height IC: 6 (15.2) Overall Dimension Length IC: 18.5 (46.9) Overall Dimension Width IC: 4 (10.2)...
The model 55D Rocking Shaker provides the same Reliable quality as the 55S, but double the value. The 55D gives you an additional platform with a height of 3.25 in....
The model 55D Rocking Shaker provides the same Reliable quality as the 55S, but double the value. The 55D gives you an additional platform with a height of 3.25 in....
Conversion Kits For Modular Incubator Chamber...
Medicine Products: